Transradial Selective Catheterization of the Celiac Artery in Obese Patients
- Conditions
- Obesity
- Interventions
- Procedure: Transradial celiac artery angiography
- Registration Number
- NCT03434665
- Lead Sponsor
- Laval University
- Brief Summary
BACKGROUND:
* Obesity, with its associated comorbidities, is set to become a major risk factor for cardiovascular disease in the 21st century. To this day, diet and medical therapy have proven only limited efficacy and bariatric surgery remains the last resort for many severely obese patients who wish to lose weight, modify their cardiovascular risk factors and ultimately modify their long-term prognosis. However, bariatric surgery remains associated with significant procedural morbidity and many patients are not eligible for such a surgery procedure as the risk-benefit ratio of bariatric surgery in severe obese patients with coronary artery disease is not yet well known.
* Recently, percutaneous left gastric artery embolization has been reported as a promising technique leading to a body weight loss that is equivalent to bariatric surgery.
* In the context of an endovascular procedure in obese patients, vascular access is a major concern. Transradial access (or radial artery approach) has been consistently associated with significant reductions in access-site related vascular complications and peri-procedural bleeding compared to the standard transfemoral access (or femoral artery approach). This is particularly evident in patients with severe obesity.
* Visceral arteries most often have an acute angulation with the aorta which makes them more easily cannulated from above (transradial access) compared to below (transfemoral access). Preliminary experience has shown that cannulation of the celiac artery is feasible from transfemoral and transradial access, the latter being associated with shorter procedural time and less contrast agent use. To date, several pilot studies have reported successful percutaneous embolization of the left gastric artery with biodegradable microspheres. This appears to be a promising technique to reduce weight in severely obese patients.
* Prior to launching a randomized trial, further study is warranted regarding the feasibility and safety aspects of transradial angiography of the celiac artery.
- Detailed Description
RATIONALE:
* A significant proportion of patients referred to IUCPQ-UL catheterization laboratory are overweight (body mass index \>25 kg/m²).
* Ongoing research and early clinical experience suggest that embolization of the left gastric artery could drastically reduce ghrelin levels and be associated with significant weight loss.
* In obese patients, catheterization using femoral artery access is associated with higher risks of vascular complications and peri-procedural bleeding compared to a radial artery approach.
* Given the anatomy (angle) of the celiac artery, selective catheterization of the celiac and left gastric arteries remains challenging, especially in obese patients.
* Before studying the effects of bariatric embolization, more data regarding the access of the left gastric artery is necessary.
HYPOTHESES:
* Transradial angiography of the celiac artery/left gastric artery is feasible and safe.
* Given the angulation of celiac artery, catheterization through a radial approach could be simpler.
* Selective angiography of the celiac artery and the left gastric artery can be performed in the setting of uncomplicated coronary angiography/percutaneous coronary intervention (PCI).
* Detailed anatomy of the celiac artery and its branches can be visualized by selective transradial angiography.
OBJECTIVES:
* The primary objective is to demonstrate the feasibility and safety of performing selective angiography of the celiac artery using a transradial approach in obese patients referred for diagnostic coronary angiography and/or PCI.
* The secondary objective is to observe anatomical variations of the celiac artery and the left gastric artery.
STUDY DESIGN:
\> A prospective pilot study performed at Quebec Heart \& Lung Institute (Institut Universitaire de Cardiologie et de Pneumologie de Québec - Université Laval; IUCPQ-UL).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 54
- Patients undergoing coronary angiography with a BMI >30 kg/m² will be eligible.
- Kidney disease defined by a glomerular filtration rate less than 60 ml/min/m² according to the Modification of Diet in Renal Disease (MDRD) formula;
- Previous gastric or bariatric surgery;
- Emergency coronary procedure.
Furthermore, the procedure will be cancelled if one of the following criteria are met during the coronary angiography:
- Contrast volume >250 ml;
- Radiation dose >180 Gy.cm² as assessed by the dose area product (DAP).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Recruited patients Transradial celiac artery angiography Transradial celiac artery angiography
- Primary Outcome Measures
Name Time Method Percentage of successful selective angiographies Baseline The primary end-point will be the percentage of successful selective angiographies of the celiac artery.
- Secondary Outcome Measures
Name Time Method Radiation exposure (dose) Baseline Dose area product (Gy·cm2) required to complete the angiography of the celiac artery
Number of catheters Baseline The number of catheters required to complete the angiography of the celiac artery
Incidence of complications of angiographies Baseline As catheterization and angiography of the celiac artery is an endovascular procedure, the incidence of vessel trauma (such as dissection or perforation) during the procedure will be assessed. All cine films will be reviewed by a multidisciplinary team.
Radiation exposure (duration) Baseline Fluoroscopy time (minutes) required to complete the angiography of the celiac artery
Contrast volume Baseline Volume (mL) of contrast required to complete the angiography of the celiac artery
Procedure duration Baseline Time (minutes) required to complete the angiography of the celiac artery
Trial Locations
- Locations (1)
Quebec Heart & Lung Institute (IUCPQ-UL)
🇨🇦Quebec City, Quebec, Canada